Viscoelastic testing inside and beyond the operating room

Journal of Thoracic Disease

Volumn 9, Issue , 2017, Pages S299-S308

  Shen, Liang ^a   Tabaie, Sheida ^a   Ivascu, Natalia ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Rotational thromboelastometry (ROTEM); Thromboelastography (TEG); Viscoelastic testing

Indexed keywords

ANTICOAGULANT AGENT; DIRECT ORAL ANTICOAGULANT; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANTICOAGULANT THERAPY; BLOOD CELL COUNT; BLOOD CLOT LYSIS; BLOOD CLOTTING DISORDER; BLOOD EXAMINATION; CLINICAL DECISION MAKING; COST EFFECTIVENESS ANALYSIS; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; EXTRACORPOREAL OXYGENATION; HEMOPHILIA; HUMAN; HYPERCOAGULABILITY; HYPOFIBRINOGENEMIA; INTERNATIONAL NORMALIZED RATIO; MEDICAL PRACTICE; MORTALITY; OBSTETRIC HEMORRHAGE; PARTIAL THROMBOPLASTIN TIME; PLASMA TRANSFUSION; POINT OF CARE TESTING; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE EVALUATION; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK REDUCTION; ROTATIONAL THROMBOELASTOMETRY; SEPSIS; SURGICAL PATIENT; SYSTEMATIC REVIEW (TOPIC); THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOELASTOGRAPHY; THROMBOEMBOLISM; THROMBOEMBOLISM RISK ASSESSMENT; TRAUMA INDUCED COAGULOPATHY; VENTRICULAR ASSIST DEVICE; VISCOELASTIC TESTING;

EID: 85018973631     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.21037/jtd.2017.03.85     Document Type: Review

References (61)

1. Karkouti K, Wijeysundera DN, Yau TM, et al. The independent association of massive blood loss with mortality in cardiac surgery. Transfusion 2004;44:1453-62
2. Clifford L, Jia Q, Yadav H, et al. Characterizing the Epidemiology of Perioperative Transfusion-associated Circulatory Overload. Anesthesiology 2015;122:21-8
3. Hall TS, Brevetti GR, Skoultchi AJ, et al. Reexploration for hemorrhage following open heart surgery differentiation on the causes of bleeding and the impact on patient outcomes. Ann Thorac Cardiovasc Surg 2001;7:352-7
4. Hardy JF, de Moerloose P, Samama CM. The coagulopathy of massive transfusion. Vox Sang 2005;89:123-7
5. Corredor C, Wasowicz M, Karkouti K, et al. The role of point-of-care platelet function testing in predicting postoperative bleeding following cardiac surgery: a systematic review and meta-analysis. Anaesthesia 2015;70:715-31
6. Lee FM, Chan AK, Lau KK, et al. Reversal of New, Factor-specific Oral Anticoagulants by rFVIIa, Prothrombin Complex Concentrate and Activated Prothrombin Complex Concentrate: A Review of Animal and Human Studies. Thromb Res 2014;133:705-13
7. Delaney M, Wendel S, Bercovitz RS, et al. Transfusion reactions: prevention, diagnosis, and treatment. Lancet 2016;388:2825-36
8. Muszynski JA, Spinella PC, Cholette JM, et al. Transfusion-related immunomodulation: review of the literature and implications for pediatric critical illness. Transfusion 2017;57:195-206
9. Briggs C, Kimber S, Green L. Where are we at with point-of-care testing in haematology? Br J Haematol 2012;158:679-90
10. Chen J, Gorman M, O'Reilly B, et al. Analytical evaluation of the epoc® point-of-care blood analysis system in cardiopulmonary bypass patients. Clin Biochem 2016;49:708-12
11. Benes J, Zatloukal J, Kletecka J. Viscoelastic Methods of Blood Clotting Assessment-A Multidisciplinary Review. Front Med (Lausanne) 2015;2:62
12. Chee YL, Greaves M. Role of coagulation testing in predicting bleeding risk. Hematol J Off J Eur Haematol Assoc 2003;4:373-8
13. Hartert H. Blutgerinnungsstudien mit der Thrombelastographie, einem neuen Untersuchungsverfahren. Klin Wochenschr 1948;26:577-83
14. Kang YG, Martin DJ, Marquez J, et al. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg 1985;64:888-96
15. Lang T, Bauters A, Braun SL, et al. Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinolysis 2005;16:301-10
16. Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005;27:81-90
17. Wikkelsø A, Wetterslev J, Møller AM, et al. Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding. In: Afshari A. editor. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd, 2016:CD007871
18. Williams B, McNeil J, Crabbe A, et al. Practical Use of Thromboelastometry in the Management of Perioperative Coagulopathy and Bleeding. Transfus Med Rev 2017;31:11-25
19. Theusinger OM, Levy JH. Point of Care Devices for Assessing Bleeding and Coagulation in the Trauma Patient. Anesthesiol Clin 2013;31:55-65
20. Ogawa S, Szlam F, Chen EP, et al. A comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution-induced coagulation changes after cardiac surgery. Transfusion 2012;52:14-22
21. Nakayama Y, Nakajima Y, Tanaka KA, et al. Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. Br J Anaesth 2015;114:91-102
22. Gorlinger K, Dirkmann D, Solomon C, et al. Fast interpretation of thromboelastometry in non-cardiac surgery: reliability in patients with hypo-, normo-, and hypercoagulability. Br J Anaesth 2013;110:222-30
23. Olde Engberink RH, Kuiper GJ, Wetzels RJ, et al. Rapid and correct prediction of thrombocytopenia and hypofibrinogenemia with rotational thromboelastometry in cardiac surgery. J Cardiothorac Vasc Anesth 2014;28:210-6
24. Rossaint R, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care 2016;20:100
25. Leemann H, Lustenberger T, Talving P, et al. The role of rotation thromboelastometry in early prediction of massive transfusion. J Trauma 2010;69:1403-8-9
26. Schöchl H, Cotton B, Inaba K, et al. FIBTEM provides early prediction of massive transfusion in trauma. Crit Care 2011;15:R265
27. Pezold M, Moore EE, Wohlauer M, et al. Viscoelastic clot strength predicts coagulation-related mortality within 15 minutes. Surgery 2012;151:48-54
28. Davenport R, Manson J, De'Ath H, et al. Functional definition and characterization of acute traumatic coagulopathy. Crit Care Med 2011;39:2652-8
29. Cotton BA, Faz G, Hatch QM, et al. Rapid thrombelastography delivers real-time results that predict transfusion within 1 hour of admission. J Trauma 2011;71:407-14; discussion 414-7
30. Chapman MP, Moore EE, Moore HB, et al. The "Death Diamond." J Trauma Acute Care Surg 2015;79:925-9
31. Hunt H, Stanworth S, Curry N, et al. Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) for trauma-induced coagulopathy in adult trauma patients with bleeding. In: Hunt H. editor. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd, 2015:CD010438
32. Da Luz LT, Nascimento B, Shankarakutty AK, et al. Effect of thromboelastography (TEG®) and rotational thromboelastometry (ROTEM®) on diagnosis of coagulopathy, transfusion guidance and mortality in trauma: descriptive systematic review. Crit Care 2014;18:518
33. Whiting P, Al M, Westwood M, et al. Viscoelastic pointof-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis. Health Technol Assess 2015;19:1-228, v-vi
34. Hans GA, Besser MW. The place of viscoelastic testing in clinical practice. Br J Haematol 2016;173:37-48
35. De Pietri L, Bianchini M, Montalti R, et al. Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: A randomized, controlled trial. Hepatology 2016;63:566-73
36. Müller MC, Meijers JC, Vroom MB, et al. Utility of thromboelastography and/or thromboelastometry in adults with sepsis: a systematic review. Crit Care 2014;18:R30
37. Brenner T, Schmidt K, Delang M, et al. Viscoelastic and aggregometric point-of-care testing in patients with septic shock-cross-links between inflammation and haemostasis. Acta Anaesthesiol Scand 2012;56:1277-90
38. Adamzik M, Langemeier T, Frey UH, et al. Comparison of thrombelastometry with simplified acute physiology score II and sequential organ failure assessment scores for the prediction of 30-day survival: a cohort study. Shock 2011;35:339-42
39. Ostrowski SR, Windeløv NA, Ibsen M, et al. Consecutive thrombelastography clot strength profiles in patients with severe sepsis and their association with 28-day mortality: A prospective study. J Crit Care 2013;28:317.e1-317.e11
40. Karlsson O, Jeppsson A, Hellgren M. Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both? Int J Obstet Anesth 2014;23:10-7
41. Collins PW, Lilley G, Bruynseels D, et al. Fibrinbased clot formation as an early and rapid biomarker for progression of postpartum hemorrhage: a prospective study. Blood 2014;124:1727-36
42. Allard S, Green L, Hunt BJ. How we manage the haematological aspects of major obstetric haemorrhage. Br J Haematol 2014;164:177-88
43. Rafiq S, Johansson PI, Ostrowski SR, et al. Hypercoagulability in patients undergoing coronary artery bypass grafting: prevalence, patient characteristics and postoperative outcome. Eur J Cardiothorac Surg 2012;41:550-5
44. Hincker A, Feit J, Sladen RN, et al. Rotational thromboelastometry predicts thromboembolic complications after major non-cardiac surgery. Crit Care 2014;18:549
45. Davies NA, Harrison NK, Sabra A, et al. Application of ROTEM to assess hypercoagulability in patients with lung cancer. Thromb Res 2015;135:1075-80
46. Van Haren RM, Valle EJ, Thorson CM, et al. Hypercoagulability and other risk factors in trauma intensive care unit patients with venous thromboembolism. J Trauma Acute Care Surg 2014;76:443-9
47. Levy JH, Faraoni D, Spring JL, et al. Managing New Oral Anticoagulants in the Perioperative and Intensive Care Unit Setting. Anesthesiology 2013;118:1466-74
48. Crapelli GB, Bianchi P, Isgrò G, et al. A Case of Fatal Bleeding Following Emergency Surgery on an Ascending Aorta Intramural Hematoma in a Patient Taking Dabigatran. J Cardiothorac Vasc Anesth 2016;30:1027-31
49. Herrmann R, Thom J, Wood A, et al. Thrombin generation using the calibrated automated thrombinoscope to assess reversibility of dabigatran and rivaroxaban. Thromb Haemost 2014;111:989-95
50. Grottke O, van Ryn J, Spronk HM, et al. Prothrombin complex concentrates and a specific antidote to dabigatran are effective ex-vivo in reversing the effects of dabigatran in an anticoagulation/liver trauma experimental model. Crit Care 2014;18:R27
51. Eller T, Busse J, Dittrich M, et al. Dabigatran, rivaroxaban, apixaban, argatroban and fondaparinux and their effects on coagulation POC and platelet function tests. Clin Chem Lab Med 2014;52:835-44
52. Tarandovskiy ID, Balandina AN, Kopylov KG, et al. Investigation of the phenotype heterogeneity in severe hemophilia A using thromboelastography, thrombin generation, and thrombodynamics. Thromb Res 2013;131:e274-80
53. Sørensen B, Ingerslev J. Tailoring haemostatic treatment to patient requirements-an update on monitoring haemostatic response using thrombelastography. Haemophilia 2005;11 Suppl 1:1-6
54. Tran HT, Sørensen B, Bjørnsen S, et al. Monitoring bypassing agent therapy-a prospective crossover study comparing thromboelastometry and thrombin generation assay. Haemophilia 2015;21:275-83
55. Görlinger K, Bergmann L, Dirkmann D. Coagulation management in patients undergoing mechanical circulatory support. Best Pract Res Clin Anaesthesiol 2012;26:179-98
56. Nair P, Hoechter DJ, Buscher H, et al. Prospective observational study of hemostatic alterations during adult extracorporeal membrane oxygenation (ECMO) using point-of-care thromboelastometry and platelet aggregometry. J Cardiothorac Vasc Anesth 2015;29:288-96
57. Boyle AJ, Russell SD, Teuteberg JJ, et al. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. J Heart Lung Transplant 2009;28:881-7
58. Schmid C, Hammel D, Deng MC, et al. Ambulatory care of patients with left ventricular assist devices. Circulation 1999;100:II224-8
59. Fries D, Innerhofer P, Streif W, et al. Coagulation monitoring and management of anticoagulation during cardiac assist device support. Ann Thorac Surg 2003;76:1593-7
60. Niemi TT, Kukkonen SI, Hämmäinen PT, et al. Whole blood hypercoagulability despite anticoagulation during mechanical cardiac assist. Perfusion 2008;23:107-10
61. Majeed F, Kop WJ, Poston RS, et al. Prospective, observational study of antiplatelet and coagulation biomarkers as predictors of thromboembolic events after implantation of ventricular assist devices. Nat Clin Pract Cardiovasc Med 2009;6:147-57